|
|
Article: Kimball Genetics, Inc. Launches the Warfarin Sensitivity DNA Test for Research.
- Article from:
- PR Newswire
- Article date:
- November 14, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DENVER, Nov. 14 /PRNewswire/ -- Kimball Genetics, Inc. is pleased to announce today the launch of its Warfarin Sensitivity DNA Test for research/investigational purposes. Warfarin is the most frequently prescribed oral anticoagulant used for the prevention and treatment of thromboembolic events. However, it is a difficult drug to manage due to its narrow therapeutic range and inconsistent patient response resulting from inter-individual variability. Genetic information available from the new pharmacogenomic test will help predict response. The Warfarin Sensitivity DNA Test determines the presence of specific variations in the CYP2C9 and VKORC1 genes that confer ...
Related newspaper, magazine, and journal articles:
|
|
Article: DNA test for colon cancer holds hope.(NEWS)
Star Tribune (Minneapolis, MN);
October 25, 2000 ;
700+ words
...An experimental DNA test that could be done at home may, in ... cancer doesn't happen." He said the DNA test was far more accurate than tests that ... Ahlquist said. By comparison, the DNA test's 91 percent accuracy rate is "a ...
|
|